FDA Approves Futibatinib for FGFR2+ Advanced Cholangiocarcinoma
- This topic has 0 replies, 1 voice, and was last updated 1 year, 6 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
FDA Approves Futibatinib for FGFR2+ Advanced Cholangiocarcinoma
https://www.targetedonc.com/view/fda-approves-futibatinib-for-fgfr2-advanced-cholangiocarcinoma
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.